Cargando...
Incorporating biomarkers to improve statistical power of immunotherapeutic neoadjuvant clinical trials in patients with triple-negative breast cancer
Neoadjuvant (preoperative) approach to breast cancer treatment has become widely accepted. Traditionally the primary objective of neoadjuvant treatment is to improve subsequent surgical intervention and the effectiveness are often evaluated by its ability achieving complete pathological response (pC...
Gardado en:
| Publicado en: | Stat Biopharm Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714581/ https://ncbi.nlm.nih.gov/pubmed/31467642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2018.1518259 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|